Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...

If you have been diagnosed with metastatic breast cancer, resources like support groups, counseling, financial assistance, and online communities can help.

A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...

Hundreds of FDA-approved drugs tested directly on a patient’s tumor sample. Could this be a gamechanger for cancer management ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Oklahoma Cancer Specialists and Research Institute has partnered with a non-profit oncology research organization, granting ...